Aims and Scope
Cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials on emerging trends and potential controversies in the field, and Review articles summarizing important areas of cell and gene therapy research that are topical and/or challenge existing paradigms in the field.
Cytotherapy considers manuscripts exploring the following topics:
- Gene, cell (includes stem cells and iPSCs) and EV-based therapies
- Regulatory frameworks and policy issues in CGT
- Novel and innovative results from basic, translational, and clinical studies in CGT
- Important advances in cell/gene-based product manufacturing,
commercialization and patient access
- Clinical studies evaluating the safety and efficacy of cell and gene therapies
Cytotherapy does not publish manuscripts on the following topics:
- Case studies unless they are of unusual significance to the field.
- Basic/translational studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiology
- Studies describing signaling pathways implicated in cancer
Mission Statement
To be the premier cell and gene therapy translation journal.